SCHEMBL939757

SCHEMBL939757

Fc1cccc(CN2CCCC2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.53
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 3/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KCNH2 Q12809 1/20 0.41
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
PRMT6 Q96LA8 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20609083 0.86 CXCR4 (0.68) CXCR4ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL18157904 0.84 CXCR4 (0.66) CXCR4ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL24306636 0.83 CXCR4 (0.47) CXCR4ALDH1A1DRD2DRD3BCHE
Hydrochloric Acid SCHEMBL29604003 0.82 CXCR4 (0.63) CXCR4ALDH1A1SMN1; SMN2KDM4EHPGD
Bromide SCHEMBL29605492 0.82 CXCR4 (0.63) CXCR4ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL18933308 0.80 LMNA (0.53) CXCR4ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL3080704 0.79 FAAH (0.44) CXCR4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL21043995 0.79 FAAH (0.44) CXCR4ALDH1A1KDM4EDRD2DRD3
SCHEMBL3080764 0.79 FAAH (0.50) CXCR4ALDH1A1SMN1; SMN2KDM4EDRD2
SCHEMBL30218427 0.79 FAAH (0.44) CXCR4ALDH1A1KDM4EDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140030223-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES, INC. (US) 2014-01-30 US disclosed
US-8569302-B2 Inhibitors of flaviviridae viruses GILEAD SCIENCES, INC. (US) 2013-10-29 US disclosed
EP-2475657-B1 5-ALKINYLTHIEN-2-YLCARBOXYLIC ACIDS AS INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES INC (US) 2013-06-12 EP disclosed
US-20110020278-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES, INC. (US) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140030223-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES HAVCR2, CYP2F1, CYP4F3 CXCR4 2800/4885ALDH1A1 462/4885SMN1; SMN2 1851/4885
US-20110020278-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES HAVCR2, CYP2F1, CYP4F3 CXCR4 2800/4885ALDH1A1 462/4885SMN1; SMN2 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.